SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as community members express strong bullish sentiment and anticipate a return to the moon. Discussions highlight the project's potential, recent milestones like exchange listings and staking, and a shared belief in defying the broken financial system. The community emphasizes a collaborative spirit, with frequent mentions of related tokens like $SLAP and $RAGE, fostering a sense of unity and shared success.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending amidst community discussions around a recent public offering and its potential implications, including speculation about debt repayment and future acquisitions. Bulls are highlighting the company's upcoming FDA meeting in December and strong data as key catalysts, while some express concern over potential dilution and short selling.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending amid a trading update and renewed investor interest in the company's SMR (small modular reactor) technology following UK government support and potential deals in Sweden. Community members are also closely watching for news from the Dubai Airshow and defense contracts, expressing optimism about the company's fundamentals and growth prospects in aerospace, defense, and power systems. Some investors are analyzing recent price action as a possible buying opportunity.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending as investors debate the impact of a recent share offering and broader AI sector sentiment. Community discussions revolve around the company's growth potential, significant deals with tech giants, and comparisons to other data center stocks. Some are concerned about dilution and profitability, while others remain bullish on the long-term prospects of Nebius Group in the expanding AI landscape.

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Korro Bio Inc.

Korro Bio is trending due to a sharp after-hours drop following disappointing clinical trial results, the postponement of a collaboration, and layoffs, prompting community discussion around the company's future and potential for a rebound given its cash reserves. Some investors believe the stock is oversold, pointing to the company's cash value, while others express concern about its prospects and the impact of tax-loss harvesting. Chatter includes short interest, potential overnight trading, and comparisons to similar situations.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending amid anticipation for a meeting between US and Chinese leaders, with many hoping for eased trade tensions and tariff reductions that could boost the stock. Bullish sentiment is building, with some traders eyeing a potential breakout towards $200 if the meeting yields positive outcomes. The community is closely watching for announcements related to trade, tariffs, and AI chip sales as potential catalysts.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global ($VG) is trending due to community discussion around potential catalysts, including long-term call options and possible short squeezes. Bullish sentiment is fueled by new long-term contracts and expectations of significant growth in LNG exports, particularly with new facilities coming online. Lawsuits and fluctuating ratings contribute to cautious optimism, with community members weighing the balance between risk and potential reward.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle ($CRCL) is trending amid discussions about its correlation to Bitcoin's volatility and anticipation for upcoming earnings, with some expecting a rise to $130. Community members highlight Cathie Wood's ARK ETF buying shares and the potential impact of the IPO lockup expiration. Despite impressive metrics, some express concerns about revenue dependence on interest rates and increasing competition.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk ($SNDK) is trending due to overnight weakness potentially driven by news or catalysts affecting the chip sector, though some community members dismiss concerns about Robinhood's trading price. Community discussion revolves around its remarkable rally, with some warning of a potential short squeeze and others predicting further gains fueled by AI and memory storage demand. Bullish sentiment remains strong, with some speculating about a possible buyout amid the cyclical upswing in the SSD market.

Global X Funds - Global X Silver Miners ETF

Global X Silver Miners ETF ($SIL) is trending as silver prices rise, fueling community discussion about potential record profits for miners and debate over whether miners will outperform silver itself. Some investors are analyzing technical indicators and discussing entry points, while others point to silver's industrial demand and potential for a short squeeze amid supply concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Catalyst Pharmaceuticals (NASDAQ:CPRX) Posts Quarterly Earnings Results, Beats Expectations By $0.18 EPS

Catalyst Pharmaceuticals (NASDAQ:CPRX - Get Free Report) issued its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.68 EPS for the quarter, topping the consensus...

Citigroup Increases Catalyst Pharmaceuticals (NASDAQ:CPRX) Price Target to $33.00

Citigroup raised their target price on Catalyst Pharmaceuticals from $31.00 to $33.00 and gave the stock a "buy" rating in a research note on Friday...

Catalyst Pharmaceuticals (NASDAQ:CPRX) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen lowered shares of Catalyst Pharmaceuticals from a "buy" rating to a "hold" rating in a research note on Saturday...

Catalyst Pharmaceuticals Q3 Earnings Beat, Firdapse Revenues Rise Y/Y

CPRX Q3 earnings and revenues beat estimates, driven by strong Firdapse and Agamree sales, while raising the full-year 2025 total revenue guidance.

Compared to Estimates, Catalyst (CPRX) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Catalyst (CPRX) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Catalyst Pharmaceutical (CPRX) Beats Q3 Earnings and Revenue Estimates

Catalyst (CPRX) delivered earnings and revenue surprises of +33.33% and +8.77%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?

Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Catalyst Pharmaceutical (CPRX) Q3 Earnings Expected to Decline

Catalyst (CPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Catalyst Pharmaceuticals Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

CPRX
Catalyst Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CPRX News

CPRXCatalyst Pharmaceuticals Inc